133 related articles for article (PubMed ID: 7590597)
21. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
22. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
Huff SY; Quilliam LA; Cox AD; Der CJ
Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
[TBL] [Abstract][Full Text] [Related]
23. Suppression of c-ras transformation by GTPase-activating protein.
Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
[TBL] [Abstract][Full Text] [Related]
24. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
[TBL] [Abstract][Full Text] [Related]
25. Suppression of various human tumor cell lines by a dominant negative H-ras mutant.
Ogiso Y; Sakai N; Watari H; Yokoyama T; Kuzumaki N
Gene Ther; 1994 Nov; 1(6):403-7. PubMed ID: 7584106
[TBL] [Abstract][Full Text] [Related]
26. Involvement of p21ras in activation of extracellular signal-regulated kinase 2.
de Vries-Smits AM; Burgering BM; Leevers SJ; Marshall CJ; Bos JL
Nature; 1992 Jun; 357(6379):602-4. PubMed ID: 1608472
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional analysis of a mutant Ras protein that is insensitive to nitric oxide activation.
Mott HR; Carpenter JW; Campbell SL
Biochemistry; 1997 Mar; 36(12):3640-4. PubMed ID: 9132016
[TBL] [Abstract][Full Text] [Related]
28. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
30. Ras in signal transduction.
Satoh T; Kaziro Y
Semin Cancer Biol; 1992 Aug; 3(4):169-77. PubMed ID: 1421161
[TBL] [Abstract][Full Text] [Related]
31. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
32. Transformational and altered signal transduction by a naturally occurring mutant EGF receptor.
Moscatello DK; Montgomery RB; Sundareshan P; McDanel H; Wong MY; Wong AJ
Oncogene; 1996 Jul; 13(1):85-96. PubMed ID: 8700557
[TBL] [Abstract][Full Text] [Related]
33. [Ras p21 and signal transduction].
Kishi K; Tanaka K; Takai Y
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1107-21. PubMed ID: 8512342
[TBL] [Abstract][Full Text] [Related]
34. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
35. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
[TBL] [Abstract][Full Text] [Related]
36. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
37. Transforming and c-fos promoter/enhancer-stimulating activities of a GDP/GTP exchange protein for small GTP-binding proteins.
Takai Y; Kaibuchi K; Kikuchi A; Kawata M; Sasaki T; Yamamoto T
Princess Takamatsu Symp; 1991; 22():197-204. PubMed ID: 1844241
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved.
Chung JY; Huang C; Meng X; Dong Z; Yang CS
Cancer Res; 1999 Sep; 59(18):4610-7. PubMed ID: 10493515
[TBL] [Abstract][Full Text] [Related]
39. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
Urich M; Senften M; Shaw PE; Ballmer-Hofer K
Oncogene; 1997 Mar; 14(10):1235-41. PubMed ID: 9121774
[TBL] [Abstract][Full Text] [Related]
40. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
